Miles W. Carroll

39.4k total citations
134 papers, 5.8k citations indexed

About

Miles W. Carroll is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Miles W. Carroll has authored 134 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 46 papers in Epidemiology and 37 papers in Immunology. Recurrent topics in Miles W. Carroll's work include Viral Infections and Outbreaks Research (43 papers), Viral Infections and Vectors (33 papers) and Virus-based gene therapy research (29 papers). Miles W. Carroll is often cited by papers focused on Viral Infections and Outbreaks Research (43 papers), Viral Infections and Vectors (33 papers) and Virus-based gene therapy research (29 papers). Miles W. Carroll collaborates with scholars based in United Kingdom, United States and Germany. Miles W. Carroll's co-authors include Bernard Moss, Nicholas P. Restifo, Steven A. Rosenberg, Linda S. Wyatt, Roger Hewson, Willem W. Overwijk, Stuart Dowall, Kari R. Irvine, Patricia L. Earl and Richard Harrop and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Miles W. Carroll

128 papers receiving 5.7k citations

Peers

Countries citing papers authored by Miles W. Carroll

Since Specialization

Citations

This map shows the geographic impact of Miles W. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles W. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles W. Carroll more than expected).

Fields of papers citing papers by Miles W. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles W. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles W. Carroll. The network helps show where Miles W. Carroll may publish in the future.

Co-authorship network of co-authors of Miles W. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Miles W. Carroll. A scholar is included among the top collaborators of Miles W. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles W. Carroll. Miles W. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management 2025 ·Journal of Virology ·Dung Nguyen, Stephen M. Laidlaw, Xiaofeng Dong, Matthew E. Wand, Amanda Horton, Mark A. Sutton, Julia A. Tree, Rachel Milligan, (unknown), David A. Matthews, (unknown), Khondaker Miraz Rahman, Julian A. Hiscox, Miles W. Carroll	1
2	Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time 2025 ·Nucleic Acids Research ·Xiaofeng Dong, David A. Matthews, Giulia Gallo, Alistair C. Darby, I’ah Donovan-Banfield, (unknown), (unknown), Todd Myers, Robert D. Orr, (unknown), Miles W. Carroll, Julian A. Hiscox	1
3	Ebola virus persistence: implications for human-to-human transmission and new outbreaks 2025 ·Exploration of Medicine ·(unknown), Kimberly Fornace, Miles W. Carroll	0
4	Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Stephen M. Laidlaw, E. Salah, (unknown), Petra Lukacik, Hani Choudhry, Martin Walsh, Miles W. Carroll, Christopher J. Schofield, Lennart Brewitz	0
5	Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic 2025 ·Microbiology Spectrum ·Stephen M. Laidlaw, David Ulaeto, (unknown), Graeme C. Clark, Rebecca P. Sumner, Thomas Edwards, Emily R. Adams, (unknown), (unknown), Carlos Maluquer de Motes, Peter Horby, Piet Maes, Miles W. Carroll	2
6	Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection 2025 ·Journal of Virology ·Xiaofeng Dong, Isabel García-Dorival, Natasha Y. Rickett, Andrew Bosworth, Sophie J. Smither, Stuart Dowall, Miles W. Carroll, David A. Matthews, Thomas R. Laws, Paul Digard, Julian A. Hiscox	0
7	Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza near migratory shorebird habitats 2024 ·Nature Communications ·(unknown), Timothy William, Jack Mellors, (unknown), Giri Shan Rajahram, Tock H. Chua, (unknown), (unknown), (unknown), Mohammad Saffree Jeffree, Nigel Temperton, Tom Tipton, Craig Thompson, Kamruddin Ahmed, Chris Drakeley, Miles W. Carroll, Kimberly Fornace	2
8	Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials 2024 ·medRxiv ·Xin Hui S Chan, (unknown), (unknown), Md Zakiul Hassan, (unknown), Tara Hurst, (unknown), (unknown), Eli Harriss, Jake Dunning, Joel Tärning, Miles W. Carroll, Peter Horby, Piero Olliaro	2
9	Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea 2024 ·Nature Communications ·Joseph Akoi Boré, (unknown), Tom Tipton, (unknown), Yper Hall, Grace Hood, Stéphanie Longet, Kimberly Fornace, (unknown), Sarah K. Fehling, (unknown), Si’Ana A. Coggins, Eric D. Laing, Christopher C. Broder, N’Fally Magassouba, Thomas Strecker, Jeremy S. Rossman, (unknown), Miles W. Carroll	9
10	Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 2023 ·Journal of General Virology ·Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, (unknown), Juthathip Mongkolsapaya, Gavin Screaton, Matthew E. Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas	1
11	256 Rescuing G542X by Adenine Base Editing: A guide to restore function 2023 ·Journal of Cystic Fibrosis ·(unknown), (unknown), (unknown), Joseph T. Costello, Miles W. Carroll, (unknown), Scott H. Randell, Deborah L. Baines, Martina Scallan, Paul F. Harrison	1
12	Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine 2023 ·Journal of Medicinal Chemistry ·Lennart Brewitz, (unknown), (unknown), David Owen, Stephen M. Laidlaw, Tika R. Malla, Dung Nguyen, Petra Lukacik, E. Salah, (unknown), Anna J. Warren, José Trincão, Claire Strain‐Damerell, Miles W. Carroll, Martin Walsh, Christopher J. Schofield	38
13	Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages 2022 ·mSphere ·Tessa Prince, Xiaofeng Dong, Rebekah Penrice-Randal, Nadine Randle, Catherine Hartley, (unknown), (unknown), Malcolm G. Semple, J. Kenneth Baillie, Peter Openshaw, Lance Turtle, Grant L. Hughes, Enyia R. Anderson, Edward I. Patterson, Julian Druce, Gavin Screaton, Miles W. Carroll, James P. Stewart, Julian A. Hiscox	5
14	Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology 2021 ·The Journal of Infectious Diseases ·Kathryn A. Ryan, (unknown), (unknown), Susan Fotheringham, Yper Hall, (unknown), Anthony C. Marriott, Jemma Paterson, Emma Rayner, Francisco J. Salguero, Robert J. Watson, Catherine Whittaker, Miles W. Carroll, Oliver Dibben	12
15	Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic 2021 ·Nature Communications ·Tom Tipton, Yper Hall, Joseph Akoi Boré, Andrew White, Laura Sibley, Charlotte Sarfas, Yuko Yuki, Maureen P. Martin, Stéphanie Longet, Jack Mellors, Katie Ewer, Stephan Günther, Mary Carrington, Mandy Kader Kondé, Miles W. Carroll	11
16	Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application 2021 ·Pathogens ·Alexander Hargreaves, (unknown), Jack Mellors, Tom Tipton, Miles W. Carroll, Stéphanie Longet	10
17	Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission 2020 ·Eurosurveillance ·Yu Xu, Kuiama Lewandowski, Louise Downs, James Kavanagh, Thomas Hender, Sheila Lumley, Katie Jeffery, Dona Foster, Nicholas Sanderson, (unknown), M. Morgan, Richard Vipond, Miles W. Carroll, Tim Peto, Derrick W. Crook, A. Sarah Walker, Philippa C. Matthews, (unknown)	1
18	Unfractionated heparin inhibits live wild type SARS‐CoV‐2 cell infectivity at therapeutically relevant concentrations 2020 ·British Journal of Pharmacology ·Julia A. Tree, Jeremy E. Turnbull, Karen R. Buttigieg, Michael J. Elmore, Naomi S. Coombes, John Hogwood, Courtney J. Mycroft‐West, Marcelo A. Lima, Mark A. Skidmore, Richard Karlsson, Yen‐Hsi Chen, Zhang Yang, C. Mirella Spalluto, Karl J. Staples, Edwin A. Yates, Elaine Gray, Dave Singh, Tom Wilkinson, Clive Page, Miles W. Carroll	62
19	Assessment of metagenomic Nanopore and Illumina sequencing for recovering whole genome sequences of chikungunya and dengue viruses directly from clinical samples 2018 ·Eurosurveillance ·Liana E. Kafetzopoulou, Kyriakos Efthymiadis, Kuiama Lewandowski, Ant Crook, Daniel Carter, Jane Osborne, Emma Aarons, Roger Hewson, Julian A. Hiscox, Miles W. Carroll, Richard Vipond, Steven T. Pullan	63
20	Sex practices and awareness of Ebola virus disease among male survivors and their partners in Guinea 2017 ·BMJ Global Health ·Mandy Kader Kondé, (unknown), (unknown), Abdoulaye Barry, (unknown), (unknown), (unknown), (unknown), N’Faly Magassouba, (unknown), Mory Keïta, Miles W. Carroll, J.M. Jansà, Lorenzo Subissi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact